Loading…

Pd()/diphosphine/curcumin complexes as potential anticancer agents

Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells. Thus, in this work, we combined Pd( ii )/phosphine systems with the natural product curcumin as a ligand, obtaining a s...

Full description

Saved in:
Bibliographic Details
Published in:Dalton transactions : an international journal of inorganic chemistry 2024-12, Vol.53 (47), p.1892-18916
Main Authors: Dutra, Jocely L, Honorato, João, Graminha, Angélica, Moraes, Carlos André F, de Oliveira, Kleber T, Cominetti, Marcia R, Castellano, Eduardo E, Batista, Alzir A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c226t-9b462fc922badda540dc8171c1bf0f8a4117d5448753c38eef05b45f954cae123
container_end_page 18916
container_issue 47
container_start_page 1892
container_title Dalton transactions : an international journal of inorganic chemistry
container_volume 53
creator Dutra, Jocely L
Honorato, João
Graminha, Angélica
Moraes, Carlos André F
de Oliveira, Kleber T
Cominetti, Marcia R
Castellano, Eduardo E
Batista, Alzir A
description Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells. Thus, in this work, we combined Pd( ii )/phosphine systems with the natural product curcumin as a ligand, obtaining a series of complexes, [Pd(cur)(PPh 3 ) 2 ]PF 6 ( A1 ), [Pd(cur)(dppe)]PF 6 ( A2 ), [Pd(cur)(dppp)]PF 6 ( A3 ), [Pd(cur)(dppb)]PF 6 ( A4 ) and [Pd(cur)(dppf)]PF 6 ( A5 ), where dppe = 1,2-bis(diphenylphosphino)ethane, dppp = 1,3-bis(diphenylphosphino)propane, dppb = 1,4-bis(diphenylphosphino)butane, and dppf = 1,1′-bis(diphenylphosphino)ferrocene (P-P), which were characterized by elemental analysis, molar conductivity analysis, and mass, NMR ( 1 H, 13 C, 31 P{ 1 H}), UV-vis, and IR spectroscopies, and four of them ( A1 , A2 , A4 , and A5 ) by X-ray crystallography. The in vitro cell viability of the complexes A1-A5 , cisplatin, and the free ligand curcumin against MDA-MB-231 (human triple-negative breast tumor cells), SK-BR-3 (human breast tumor cells), A549 (human lung tumor cells), MRC-5 (non-tumor human lung cells), A2780 (human ovarian carcinoma cells), and A2780cis (cisplatin-resistant human ovarian carcinoma cells), was evaluated by the MTT colorimetric assay. For the tumor cell lines tested, the complexes showed good anticancer activities. The results showed that in general the complexes had lower IC 50 values than free curcumin and the precursors [PdCl 2 (P-P)]. IC 50 results obtained for the A1-A5 complexes, in the MCF-7 cell line, are similar to those that had already been observed for some Pd/bipy/curcumin complexes. In the MDA-MB-231 cell line, complexes A1 and A5 stood out, with their lowest IC 50 values, around 5 μmol L −1 , and the complexes appeared to be more active (lower IC 50 values) against the ovarian cell lines. Complex A1 was 23 and 22-fold more cytotoxic than cisplatin, against the A2780 and A2780cis cells, respectively. The complex A1 was studied on A2780cis cells and it was found that this complex inhibits colony formation and induces cell cycle arrest in the sub-G1 phase in a concentration-dependent manner and leads to cell death by apoptosis. The DCFDA assay revealed a potent ROS induction for complex A1 . Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells.
doi_str_mv 10.1039/d4dt01045k
format article
fullrecord <record><control><sourceid>proquest_rsc_p</sourceid><recordid>TN_cdi_rsc_primary_d4dt01045k</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3073232618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c226t-9b462fc922badda540dc8171c1bf0f8a4117d5448753c38eef05b45f954cae123</originalsourceid><addsrcrecordid>eNpdkUtLw0AUhQdRbK1u3CsBN1WImWcnWWrrCwu6qOswmYdNTTJxJgH99462VnB1Lvd-HA7nAnCM4CWCJEsUVR1EkLK3HTBElPM4w4Tubmc8GYAD71cQYgwZ3gcDkmYkRTgbgutnNT5PVNkurW-XZaMT2TvZ12UTSVu3lf7QPhI-am2nm64UVSSCSNFI7SLxGnb-EOwZUXl9tNEReLm9WUzv4_nT3cP0ah7LkKCLs4JOsJEhTiGUEoxCJVPEkUSFgSYVFCGuGKUpZ0SSVGsDWUGZyRiVQiNMRmC89m2dfe-17_K69FJXlWi07X1OICeY4AlKA3r2D13Z3jUhXU4QYZBwzGmgLtaUdNZ7p03eurIW7jNHMP9uNp_R2eKn2ccAn24s-6LWaov-VhmAkzXgvNxe_15DvgDLBHxP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3135037274</pqid></control><display><type>article</type><title>Pd()/diphosphine/curcumin complexes as potential anticancer agents</title><source>Royal Society of Chemistry</source><creator>Dutra, Jocely L ; Honorato, João ; Graminha, Angélica ; Moraes, Carlos André F ; de Oliveira, Kleber T ; Cominetti, Marcia R ; Castellano, Eduardo E ; Batista, Alzir A</creator><creatorcontrib>Dutra, Jocely L ; Honorato, João ; Graminha, Angélica ; Moraes, Carlos André F ; de Oliveira, Kleber T ; Cominetti, Marcia R ; Castellano, Eduardo E ; Batista, Alzir A</creatorcontrib><description>Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells. Thus, in this work, we combined Pd( ii )/phosphine systems with the natural product curcumin as a ligand, obtaining a series of complexes, [Pd(cur)(PPh 3 ) 2 ]PF 6 ( A1 ), [Pd(cur)(dppe)]PF 6 ( A2 ), [Pd(cur)(dppp)]PF 6 ( A3 ), [Pd(cur)(dppb)]PF 6 ( A4 ) and [Pd(cur)(dppf)]PF 6 ( A5 ), where dppe = 1,2-bis(diphenylphosphino)ethane, dppp = 1,3-bis(diphenylphosphino)propane, dppb = 1,4-bis(diphenylphosphino)butane, and dppf = 1,1′-bis(diphenylphosphino)ferrocene (P-P), which were characterized by elemental analysis, molar conductivity analysis, and mass, NMR ( 1 H, 13 C, 31 P{ 1 H}), UV-vis, and IR spectroscopies, and four of them ( A1 , A2 , A4 , and A5 ) by X-ray crystallography. The in vitro cell viability of the complexes A1-A5 , cisplatin, and the free ligand curcumin against MDA-MB-231 (human triple-negative breast tumor cells), SK-BR-3 (human breast tumor cells), A549 (human lung tumor cells), MRC-5 (non-tumor human lung cells), A2780 (human ovarian carcinoma cells), and A2780cis (cisplatin-resistant human ovarian carcinoma cells), was evaluated by the MTT colorimetric assay. For the tumor cell lines tested, the complexes showed good anticancer activities. The results showed that in general the complexes had lower IC 50 values than free curcumin and the precursors [PdCl 2 (P-P)]. IC 50 results obtained for the A1-A5 complexes, in the MCF-7 cell line, are similar to those that had already been observed for some Pd/bipy/curcumin complexes. In the MDA-MB-231 cell line, complexes A1 and A5 stood out, with their lowest IC 50 values, around 5 μmol L −1 , and the complexes appeared to be more active (lower IC 50 values) against the ovarian cell lines. Complex A1 was 23 and 22-fold more cytotoxic than cisplatin, against the A2780 and A2780cis cells, respectively. The complex A1 was studied on A2780cis cells and it was found that this complex inhibits colony formation and induces cell cycle arrest in the sub-G1 phase in a concentration-dependent manner and leads to cell death by apoptosis. The DCFDA assay revealed a potent ROS induction for complex A1 . Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells.</description><identifier>ISSN: 1477-9226</identifier><identifier>ISSN: 1477-9234</identifier><identifier>EISSN: 1477-9234</identifier><identifier>DOI: 10.1039/d4dt01045k</identifier><identifier>PMID: 38938129</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Anticancer properties ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Cancer ; Cell cycle ; Cell death ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; Chemical analysis ; Coordination Complexes - chemical synthesis ; Coordination Complexes - chemistry ; Coordination Complexes - pharmacology ; Crystallography ; Curcumin - chemistry ; Curcumin - pharmacology ; Cytotoxicity ; Drug Screening Assays, Antitumor ; Ethane ; Humans ; Ligands ; Lungs ; Molecular Structure ; Natural products ; NMR ; Nuclear magnetic resonance ; Ovaries ; Palladium ; Palladium - chemistry ; Palladium - pharmacology ; Phosphines ; Phosphines - chemistry ; Phosphines - pharmacology ; Toxicity ; Tumors</subject><ispartof>Dalton transactions : an international journal of inorganic chemistry, 2024-12, Vol.53 (47), p.1892-18916</ispartof><rights>Copyright Royal Society of Chemistry 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c226t-9b462fc922badda540dc8171c1bf0f8a4117d5448753c38eef05b45f954cae123</cites><orcidid>0000-0001-6385-7392 ; 0000-0002-1127-6083 ; 0000-0002-4671-2754 ; 0000-0002-1911-2470 ; 0000-0002-9131-4800</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38938129$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dutra, Jocely L</creatorcontrib><creatorcontrib>Honorato, João</creatorcontrib><creatorcontrib>Graminha, Angélica</creatorcontrib><creatorcontrib>Moraes, Carlos André F</creatorcontrib><creatorcontrib>de Oliveira, Kleber T</creatorcontrib><creatorcontrib>Cominetti, Marcia R</creatorcontrib><creatorcontrib>Castellano, Eduardo E</creatorcontrib><creatorcontrib>Batista, Alzir A</creatorcontrib><title>Pd()/diphosphine/curcumin complexes as potential anticancer agents</title><title>Dalton transactions : an international journal of inorganic chemistry</title><addtitle>Dalton Trans</addtitle><description>Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells. Thus, in this work, we combined Pd( ii )/phosphine systems with the natural product curcumin as a ligand, obtaining a series of complexes, [Pd(cur)(PPh 3 ) 2 ]PF 6 ( A1 ), [Pd(cur)(dppe)]PF 6 ( A2 ), [Pd(cur)(dppp)]PF 6 ( A3 ), [Pd(cur)(dppb)]PF 6 ( A4 ) and [Pd(cur)(dppf)]PF 6 ( A5 ), where dppe = 1,2-bis(diphenylphosphino)ethane, dppp = 1,3-bis(diphenylphosphino)propane, dppb = 1,4-bis(diphenylphosphino)butane, and dppf = 1,1′-bis(diphenylphosphino)ferrocene (P-P), which were characterized by elemental analysis, molar conductivity analysis, and mass, NMR ( 1 H, 13 C, 31 P{ 1 H}), UV-vis, and IR spectroscopies, and four of them ( A1 , A2 , A4 , and A5 ) by X-ray crystallography. The in vitro cell viability of the complexes A1-A5 , cisplatin, and the free ligand curcumin against MDA-MB-231 (human triple-negative breast tumor cells), SK-BR-3 (human breast tumor cells), A549 (human lung tumor cells), MRC-5 (non-tumor human lung cells), A2780 (human ovarian carcinoma cells), and A2780cis (cisplatin-resistant human ovarian carcinoma cells), was evaluated by the MTT colorimetric assay. For the tumor cell lines tested, the complexes showed good anticancer activities. The results showed that in general the complexes had lower IC 50 values than free curcumin and the precursors [PdCl 2 (P-P)]. IC 50 results obtained for the A1-A5 complexes, in the MCF-7 cell line, are similar to those that had already been observed for some Pd/bipy/curcumin complexes. In the MDA-MB-231 cell line, complexes A1 and A5 stood out, with their lowest IC 50 values, around 5 μmol L −1 , and the complexes appeared to be more active (lower IC 50 values) against the ovarian cell lines. Complex A1 was 23 and 22-fold more cytotoxic than cisplatin, against the A2780 and A2780cis cells, respectively. The complex A1 was studied on A2780cis cells and it was found that this complex inhibits colony formation and induces cell cycle arrest in the sub-G1 phase in a concentration-dependent manner and leads to cell death by apoptosis. The DCFDA assay revealed a potent ROS induction for complex A1 . Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells.</description><subject>Anticancer properties</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Cancer</subject><subject>Cell cycle</subject><subject>Cell death</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Chemical analysis</subject><subject>Coordination Complexes - chemical synthesis</subject><subject>Coordination Complexes - chemistry</subject><subject>Coordination Complexes - pharmacology</subject><subject>Crystallography</subject><subject>Curcumin - chemistry</subject><subject>Curcumin - pharmacology</subject><subject>Cytotoxicity</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Ethane</subject><subject>Humans</subject><subject>Ligands</subject><subject>Lungs</subject><subject>Molecular Structure</subject><subject>Natural products</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Ovaries</subject><subject>Palladium</subject><subject>Palladium - chemistry</subject><subject>Palladium - pharmacology</subject><subject>Phosphines</subject><subject>Phosphines - chemistry</subject><subject>Phosphines - pharmacology</subject><subject>Toxicity</subject><subject>Tumors</subject><issn>1477-9226</issn><issn>1477-9234</issn><issn>1477-9234</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdkUtLw0AUhQdRbK1u3CsBN1WImWcnWWrrCwu6qOswmYdNTTJxJgH99462VnB1Lvd-HA7nAnCM4CWCJEsUVR1EkLK3HTBElPM4w4Tubmc8GYAD71cQYgwZ3gcDkmYkRTgbgutnNT5PVNkurW-XZaMT2TvZ12UTSVu3lf7QPhI-am2nm64UVSSCSNFI7SLxGnb-EOwZUXl9tNEReLm9WUzv4_nT3cP0ah7LkKCLs4JOsJEhTiGUEoxCJVPEkUSFgSYVFCGuGKUpZ0SSVGsDWUGZyRiVQiNMRmC89m2dfe-17_K69FJXlWi07X1OICeY4AlKA3r2D13Z3jUhXU4QYZBwzGmgLtaUdNZ7p03eurIW7jNHMP9uNp_R2eKn2ccAn24s-6LWaov-VhmAkzXgvNxe_15DvgDLBHxP</recordid><startdate>20241203</startdate><enddate>20241203</enddate><creator>Dutra, Jocely L</creator><creator>Honorato, João</creator><creator>Graminha, Angélica</creator><creator>Moraes, Carlos André F</creator><creator>de Oliveira, Kleber T</creator><creator>Cominetti, Marcia R</creator><creator>Castellano, Eduardo E</creator><creator>Batista, Alzir A</creator><general>Royal Society of Chemistry</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6385-7392</orcidid><orcidid>https://orcid.org/0000-0002-1127-6083</orcidid><orcidid>https://orcid.org/0000-0002-4671-2754</orcidid><orcidid>https://orcid.org/0000-0002-1911-2470</orcidid><orcidid>https://orcid.org/0000-0002-9131-4800</orcidid></search><sort><creationdate>20241203</creationdate><title>Pd()/diphosphine/curcumin complexes as potential anticancer agents</title><author>Dutra, Jocely L ; Honorato, João ; Graminha, Angélica ; Moraes, Carlos André F ; de Oliveira, Kleber T ; Cominetti, Marcia R ; Castellano, Eduardo E ; Batista, Alzir A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c226t-9b462fc922badda540dc8171c1bf0f8a4117d5448753c38eef05b45f954cae123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anticancer properties</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Cancer</topic><topic>Cell cycle</topic><topic>Cell death</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Chemical analysis</topic><topic>Coordination Complexes - chemical synthesis</topic><topic>Coordination Complexes - chemistry</topic><topic>Coordination Complexes - pharmacology</topic><topic>Crystallography</topic><topic>Curcumin - chemistry</topic><topic>Curcumin - pharmacology</topic><topic>Cytotoxicity</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Ethane</topic><topic>Humans</topic><topic>Ligands</topic><topic>Lungs</topic><topic>Molecular Structure</topic><topic>Natural products</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Ovaries</topic><topic>Palladium</topic><topic>Palladium - chemistry</topic><topic>Palladium - pharmacology</topic><topic>Phosphines</topic><topic>Phosphines - chemistry</topic><topic>Phosphines - pharmacology</topic><topic>Toxicity</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dutra, Jocely L</creatorcontrib><creatorcontrib>Honorato, João</creatorcontrib><creatorcontrib>Graminha, Angélica</creatorcontrib><creatorcontrib>Moraes, Carlos André F</creatorcontrib><creatorcontrib>de Oliveira, Kleber T</creatorcontrib><creatorcontrib>Cominetti, Marcia R</creatorcontrib><creatorcontrib>Castellano, Eduardo E</creatorcontrib><creatorcontrib>Batista, Alzir A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><jtitle>Dalton transactions : an international journal of inorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dutra, Jocely L</au><au>Honorato, João</au><au>Graminha, Angélica</au><au>Moraes, Carlos André F</au><au>de Oliveira, Kleber T</au><au>Cominetti, Marcia R</au><au>Castellano, Eduardo E</au><au>Batista, Alzir A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pd()/diphosphine/curcumin complexes as potential anticancer agents</atitle><jtitle>Dalton transactions : an international journal of inorganic chemistry</jtitle><addtitle>Dalton Trans</addtitle><date>2024-12-03</date><risdate>2024</risdate><volume>53</volume><issue>47</issue><spage>1892</spage><epage>18916</epage><pages>1892-18916</pages><issn>1477-9226</issn><issn>1477-9234</issn><eissn>1477-9234</eissn><abstract>Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells. Thus, in this work, we combined Pd( ii )/phosphine systems with the natural product curcumin as a ligand, obtaining a series of complexes, [Pd(cur)(PPh 3 ) 2 ]PF 6 ( A1 ), [Pd(cur)(dppe)]PF 6 ( A2 ), [Pd(cur)(dppp)]PF 6 ( A3 ), [Pd(cur)(dppb)]PF 6 ( A4 ) and [Pd(cur)(dppf)]PF 6 ( A5 ), where dppe = 1,2-bis(diphenylphosphino)ethane, dppp = 1,3-bis(diphenylphosphino)propane, dppb = 1,4-bis(diphenylphosphino)butane, and dppf = 1,1′-bis(diphenylphosphino)ferrocene (P-P), which were characterized by elemental analysis, molar conductivity analysis, and mass, NMR ( 1 H, 13 C, 31 P{ 1 H}), UV-vis, and IR spectroscopies, and four of them ( A1 , A2 , A4 , and A5 ) by X-ray crystallography. The in vitro cell viability of the complexes A1-A5 , cisplatin, and the free ligand curcumin against MDA-MB-231 (human triple-negative breast tumor cells), SK-BR-3 (human breast tumor cells), A549 (human lung tumor cells), MRC-5 (non-tumor human lung cells), A2780 (human ovarian carcinoma cells), and A2780cis (cisplatin-resistant human ovarian carcinoma cells), was evaluated by the MTT colorimetric assay. For the tumor cell lines tested, the complexes showed good anticancer activities. The results showed that in general the complexes had lower IC 50 values than free curcumin and the precursors [PdCl 2 (P-P)]. IC 50 results obtained for the A1-A5 complexes, in the MCF-7 cell line, are similar to those that had already been observed for some Pd/bipy/curcumin complexes. In the MDA-MB-231 cell line, complexes A1 and A5 stood out, with their lowest IC 50 values, around 5 μmol L −1 , and the complexes appeared to be more active (lower IC 50 values) against the ovarian cell lines. Complex A1 was 23 and 22-fold more cytotoxic than cisplatin, against the A2780 and A2780cis cells, respectively. The complex A1 was studied on A2780cis cells and it was found that this complex inhibits colony formation and induces cell cycle arrest in the sub-G1 phase in a concentration-dependent manner and leads to cell death by apoptosis. The DCFDA assay revealed a potent ROS induction for complex A1 . Palladium( ii ) complexes have stimulated research interest mainly due to their in vitro cytotoxicity against various cancer cell lines and their low cytotoxicity in healthy cells.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>38938129</pmid><doi>10.1039/d4dt01045k</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0001-6385-7392</orcidid><orcidid>https://orcid.org/0000-0002-1127-6083</orcidid><orcidid>https://orcid.org/0000-0002-4671-2754</orcidid><orcidid>https://orcid.org/0000-0002-1911-2470</orcidid><orcidid>https://orcid.org/0000-0002-9131-4800</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1477-9226
ispartof Dalton transactions : an international journal of inorganic chemistry, 2024-12, Vol.53 (47), p.1892-18916
issn 1477-9226
1477-9234
1477-9234
language eng
recordid cdi_rsc_primary_d4dt01045k
source Royal Society of Chemistry
subjects Anticancer properties
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Cancer
Cell cycle
Cell death
Cell Line, Tumor
Cell Proliferation - drug effects
Cell Survival - drug effects
Chemical analysis
Coordination Complexes - chemical synthesis
Coordination Complexes - chemistry
Coordination Complexes - pharmacology
Crystallography
Curcumin - chemistry
Curcumin - pharmacology
Cytotoxicity
Drug Screening Assays, Antitumor
Ethane
Humans
Ligands
Lungs
Molecular Structure
Natural products
NMR
Nuclear magnetic resonance
Ovaries
Palladium
Palladium - chemistry
Palladium - pharmacology
Phosphines
Phosphines - chemistry
Phosphines - pharmacology
Toxicity
Tumors
title Pd()/diphosphine/curcumin complexes as potential anticancer agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A44%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_rsc_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pd()/diphosphine/curcumin%20complexes%20as%20potential%20anticancer%20agents&rft.jtitle=Dalton%20transactions%20:%20an%20international%20journal%20of%20inorganic%20chemistry&rft.au=Dutra,%20Jocely%20L&rft.date=2024-12-03&rft.volume=53&rft.issue=47&rft.spage=1892&rft.epage=18916&rft.pages=1892-18916&rft.issn=1477-9226&rft.eissn=1477-9234&rft_id=info:doi/10.1039/d4dt01045k&rft_dat=%3Cproquest_rsc_p%3E3073232618%3C/proquest_rsc_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c226t-9b462fc922badda540dc8171c1bf0f8a4117d5448753c38eef05b45f954cae123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3135037274&rft_id=info:pmid/38938129&rfr_iscdi=true